S&P 500   4,397.94 (-1.89%)
DOW   34,265.37 (-1.30%)
QQQ   351.69 (-2.77%)
AAPL   162.41 (-1.28%)
MSFT   296.03 (-1.85%)
FB   303.17 (-4.23%)
GOOGL   2,607.03 (-2.22%)
AMZN   2,852.86 (-5.95%)
TSLA   943.90 (-5.26%)
NVDA   233.74 (-3.21%)
BABA   123.23 (-5.95%)
NIO   27.35 (-6.11%)
AMD   118.81 (-2.53%)
CGC   7.29 (-3.57%)
MU   81.93 (-3.69%)
GE   96.30 (-1.98%)
T   26.61 (-1.52%)
F   20.65 (-4.62%)
DIS   137.38 (-6.94%)
AMC   17.97 (-0.55%)
PFE   52.79 (-2.33%)
ACB   4.46 (-6.11%)
BA   205.44 (-4.09%)
S&P 500   4,397.94 (-1.89%)
DOW   34,265.37 (-1.30%)
QQQ   351.69 (-2.77%)
AAPL   162.41 (-1.28%)
MSFT   296.03 (-1.85%)
FB   303.17 (-4.23%)
GOOGL   2,607.03 (-2.22%)
AMZN   2,852.86 (-5.95%)
TSLA   943.90 (-5.26%)
NVDA   233.74 (-3.21%)
BABA   123.23 (-5.95%)
NIO   27.35 (-6.11%)
AMD   118.81 (-2.53%)
CGC   7.29 (-3.57%)
MU   81.93 (-3.69%)
GE   96.30 (-1.98%)
T   26.61 (-1.52%)
F   20.65 (-4.62%)
DIS   137.38 (-6.94%)
AMC   17.97 (-0.55%)
PFE   52.79 (-2.33%)
ACB   4.46 (-6.11%)
BA   205.44 (-4.09%)
S&P 500   4,397.94 (-1.89%)
DOW   34,265.37 (-1.30%)
QQQ   351.69 (-2.77%)
AAPL   162.41 (-1.28%)
MSFT   296.03 (-1.85%)
FB   303.17 (-4.23%)
GOOGL   2,607.03 (-2.22%)
AMZN   2,852.86 (-5.95%)
TSLA   943.90 (-5.26%)
NVDA   233.74 (-3.21%)
BABA   123.23 (-5.95%)
NIO   27.35 (-6.11%)
AMD   118.81 (-2.53%)
CGC   7.29 (-3.57%)
MU   81.93 (-3.69%)
GE   96.30 (-1.98%)
T   26.61 (-1.52%)
F   20.65 (-4.62%)
DIS   137.38 (-6.94%)
AMC   17.97 (-0.55%)
PFE   52.79 (-2.33%)
ACB   4.46 (-6.11%)
BA   205.44 (-4.09%)
S&P 500   4,397.94 (-1.89%)
DOW   34,265.37 (-1.30%)
QQQ   351.69 (-2.77%)
AAPL   162.41 (-1.28%)
MSFT   296.03 (-1.85%)
FB   303.17 (-4.23%)
GOOGL   2,607.03 (-2.22%)
AMZN   2,852.86 (-5.95%)
TSLA   943.90 (-5.26%)
NVDA   233.74 (-3.21%)
BABA   123.23 (-5.95%)
NIO   27.35 (-6.11%)
AMD   118.81 (-2.53%)
CGC   7.29 (-3.57%)
MU   81.93 (-3.69%)
GE   96.30 (-1.98%)
T   26.61 (-1.52%)
F   20.65 (-4.62%)
DIS   137.38 (-6.94%)
AMC   17.97 (-0.55%)
PFE   52.79 (-2.33%)
ACB   4.46 (-6.11%)
BA   205.44 (-4.09%)

MakeMyTrip Stock is an Under-the-Radar Play

Wednesday, December 1, 2021 | Jea Yu
MakeMyTrip Stock is an Under-the-Radar PlayOnline travel agency (OTA) MakeMyTrip (NASDAQ: MMYT) stock is attempting to coil on the continuing spread of COVID-19 vaccinations. The rapidly growing Indian market travel platform was a pandemic loser transformed into a benefactor of the reopening. COVID-19 vaccinations has been the driver for consumers taking trips again to and from India. As of November 8, 2021, the U.S. has opened up its borders to enable fully vaccinated Indian travelers to travel into the U.S. Additionally, ecommerce users are expected to grow to 500 million by 2030, more than doubling the current users today. India has the second-largest population on the planet with over 1.2 billion people. MakeMyTrip has recovery and ecommerce growth tailwinds in its favor. Prudent investors seeking exposure in travel segment in the second largest populace can watch for opportunistic pullbacks in shares of MakeMyTrip.

Q2 FY 2021 Earnings Release

On Oct. 26, 2021, MakeMyTrip released its fiscal second-quarter 2021 results for the quarter ending September 2021. The Company reported an earnings-per-share (EPS) profit of $0.09 excluding non-recurring items versus consensus analyst estimates for a loss of (-$0.08), a $0.17 beat. Revenues grew  274.2% year-over-year (YoY) to $86.4 million beating analyst estimates for $10.45 million. “MakeMyTrip continued to lead and be instrumental in the recovery of travel in India as the country’s new daily reported COVID-19 infections have declined significantly since May 2021, aided by over one billion vaccine doses that have been administered so far. The results of the reported fiscal quarter clearly showcases the durable strength of its multiple brands, driven by its relentless focus on serving its customers with the best possible experience for their travel booking needs.” said Deep Kalra, Group Executive Chairman. “Entering the peak festive season in India, we are optimistic about the expected ongoing recovery of travel demand in the quarters to come and will continue to leverage our highly variable and more efficient fixed cost structure to maintain our leading position in the travel market in India.”

Conference Call Takeaways

CEO Kalra set the tone, “On our last call in late July, we shared that India was already seeing a massive reduction in the number of daily new infections since the second wave peaked in early May this year. The good news is that, new daily infections have remained relatively muted with about 16,000 daily new cases on a seven-day average basis. We believe helping to drive this progress has been the dramatic increase in vaccinations since late July, and natural immunity from unreported vaccinations pardon me – from unreported infections during the second wave. As of last week, over one billion doses of the vaccine had already been administered according across the country, which is a significant global landmark. Nearly 300 million of our own citizens are now fully vaccinated, and we expect that number to rise as many will receive their second dose in the coming months. It's encouraging to see that promoting social distancing and use of masks is gradually helping to restore normalcy, which has quickly spilled over to travel demand. As of last week, the Directorate General of Civil Aviation or DGCA had lifted the cap for domestic flights restored domestic seat capacity back to 100% and done away with many other restrictions. While scheduled international flights remain suspended for now India has implemented travel bubble arrangements with 28 countries, including the US, Canada, the UK, many EU countries, the UAE, Qatar, and the Maldives. With declining COVID cases across India starting November 8th, the US will allow fully vaccinated Indian travelers to enter. Similarly, the UK had already relaxed quarantine requirements since October 11. India has also reopened its borders to fully vaccinated inbound tourists on chartered flights in mid-October.” He concluded, “We're even more enthused by the fundamental shift in buying behavior that has taken place during the last six quarters. A recent comment from RedSeer Consulting is predicting that e-commerce users in India will reach 500 million to 600 million by 2030, up from the roughly 150 million to 200 million today. This prediction, which is likely to play out will place India only second to China in terms of the overall size of online shoppers, equating to an expected TAM or total addressable market of $350 billion. We fundamentally believe that the long-term upside for our business remains huge, and we continue to adapt and drive innovations to keep pace with ever changing online traveler's needs.”

MakeMyTrip Stock is an Under-the-Radar Play

MMPT Opportunistic Pullback Levels

Using the rifle charts on the weekly and daily time frames provides a precision view of the playing field for MMPT shares. The weekly rifle chart peaked near the $35.88 Fibonacci (fib) level. The weekly rifle chart uptrend was abruptly shaken as shares fell under the 5-period moving average (MA) at $32.49 as it quickly tightened to the 15-period MA at $28.73. The weekly stochastic stalled just under the 80-band as the weekly uptrend stalls for a potential pup or breakdown. The weekly market structure high (MSH) sell triggers on a breakdown under $25.43. The weekly  market structure low (MSL) buy triggers above the $29.33 level. The daily rifle chart breakdown formed on the daily stochastic mini inverse pup sending the stochastic to the 20-band. Shares even overshot the daily lower Bollinger Bands (BBs) at $29.14. The daily 5-period MA is falling at $31.60. Prudent investors can look for opportunistic pullback levels at the $28.06 fib, $26.22 fib, $25.61 fib, $24.09 fib, $22.77 fib, and the $20.50 fib level. Upside trajectories range from the $35.88 fib up towards the $40.99 fib.

Should you invest $1,000 in MakeMyTrip right now?

Before you consider MakeMyTrip, you'll want to hear this.

MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and MakeMyTrip wasn't on the list.

While MakeMyTrip currently has a "Buy" rating among analysts, top-rated analysts believe these five stocks are better buys.

View The 5 Stocks Here

 


Companies Mentioned in This Article

CompanyMarketRank™Current PricePrice ChangeDividend YieldP/E RatioConsensus RatingConsensus Price Target
MakeMyTrip (MMYT)1.6$26.15-1.3%N/A-90.17Buy$37.00
Compare These Stocks  Add These Stocks to My Watchlist 

Resources

Premium Research Tools

MarketBeat All Access subscribers can access stock screeners, the Idea Engine, data export tools, research reports, and other premium tools.

Discover All Access

Market Data and Calendars

Looking for new stock ideas? Want to see which stocks are moving? View our full suite of financial calendars and market data tables, all for free.

View Market Data

Investing Education and Resources

Receive a free world-class investing education from MarketBeat. Learn about financial terms, types of investments, trading strategies and more.

Financial Terms
Details Here
MarketBeat - Stock Market News and Research Tools logo

MarketBeat empowers individual investors to make better trading decisions by providing real-time financial data and objective market analysis. Whether you’re looking for analyst ratings, corporate buybacks, dividends, earnings, economic reports, financials, insider trades, IPOs, SEC filings or stock splits, MarketBeat has the objective information you need to analyze any stock. Learn more about MarketBeat.

MarketBeat is accredited by the Better Business Bureau

© American Consumer News, LLC dba MarketBeat® 2010-2022. All rights reserved.
326 E 8th St #105, Sioux Falls, SD 57103 | U.S. Based Support Team at [email protected] | (844) 978-6257
MarketBeat does not provide personalized financial advice and does not issue recommendations or offers to buy stock or sell any security.

Our Accessibility Statement | Terms of Service | Do Not Sell My Information | RSS Feeds

© 2022 Market data provided is at least 10-minutes delayed and hosted by Barchart Solutions. Information is provided 'as-is' and solely for informational purposes, not for trading purposes or advice, and is delayed. To see all exchange delays and terms of use please see disclaimer. Fundamental company data provided by Zacks Investment Research.